United States · FDA National Drug Code directory
Topotecan hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45963-615_0edbf531-9ae9-4f9d-a606-f8f56768ce9d
- Product NDC
- 45963-615
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Topotecan hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150105
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPOTECAN HYDROCHLORIDE — 4 mg/4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL · 45963-615-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →